Navigation Links
Dr. Iffath Abbasi Hoskins Joins Americord's Advisory Board

NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on high-risk and complicated pregnancies.

"We are so pleased that Dr. Hoskins has agreed to join Americord's Advisory Board," said Americord CEO Martin Smithmyer. "She brings a wealth of experience in pregnancy and childbirth that is valuable to us as we pursue innovative technologies in the field of cord blood banking." Americord's Executive Medical Director, Dr. Robert Dracker, a highly regarded stem cell banking leader, and Dr. Eric Adler, a specialist in cardiovascular medicine who has done extensive research in the field of stem cells, are also members of the Advisory Board.

Dr. Hoskins and her colleagues are currently involved in investigations in areas pertaining to maternal and fetal well being, including antepartum fetal heart rate testing, fetal ultrasonography, maternal screening, obstetrical surgical techniques, maternal acid base status, and obstetrical complications including placenta previa. She is also involved in an ongoing investigation in the area of the pathogenesis and diagnosis of chorioamnionitis. Specifically, studying leukocyte and other esterases' activity for the diagnosis of this infection, the long-term goal being to develop a rapid simple, reliable assay for detecting chorioamnionitis in pregnancy and labor.

Dr. Hoskins has co-authored numerous scientific articles on pregnancy and childbirth for various medical publications. Dr. Hoskins earned her medical degree from Dow Medical College in Pakistan.

About Americord Registry Americord is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord's website at for more information. You may also find Americord on Facebook and follow the company on Twitter.Contact: Andrew FlookAmericord

SOURCE Americord Registry
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
2. Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff
3. Todd Rider Joins Draper to Continue Antiviral Therapeutics Development
4. Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer
5. Dr. Daniel Von Hoff Joins Lixte Biotechnologys Scientific Advisory Board
6. Bioentrepreneurship Leader Joins UM Ventures Team
7. Anthony A. Charity Joins Tunnell Consulting
8. CHI Joins More Than 30 State Life Sciences Associations in Urging Budget Conferees to Fix FDA User Fee Sequester
9. Craig Peloquin Joins Glissandra Skin Care as VP of Sales and Marketing
10. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
11. Dr. Ungerleider Joins Forces with Childhelp
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):